Search This Blog

Monday, February 8, 2010

MS Oral Treatment Studies in NEJM

The New England Journal of Medicine has published three important clinical studies of an oral dose treatment for relapsing remitting multiple sclerosis:
On-campus link
Off-campus link
Creative Commons License
Taylor Med Info is licensed under a Creative Commons Attribution-Non-Commercial-Share Alike 2.5 Canada License.
Based on a work at taylormedinfo.blogspot.com.